4//SEC Filing
LEVINE ARNOLD J 4
Accession 0001209191-21-047747
CIK 0001699382other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 4:28 PM ET
Size
7.5 KB
Accession
0001209191-21-047747
Insider Transaction Report
Form 4
LEVINE ARNOLD J
Director
Transactions
- Sale
Common Stock
2021-07-20$35.12/sh−3,500$122,929→ 416,842 total - Award
Stock Option (right to buy)
2021-05-12+5,781→ 5,781 totalExercise: $28.33Exp: 2031-05-11→ Common Stock (5,781 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.54 to $35.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares subject to the option vest in 36 equal monthly installments beginning on June 12, 2021.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001124164
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 4:28 PM ET
- Size
- 7.5 KB